IDPH--Positive preliminary results for pivotal trial of ID

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
IDPH--Positive preliminary results for pivotal trial of ID

An SI Board Since June 1996

Posts	SubjectMarks	Bans	Symbol
1762	27	0	IDPH

Emcee: Roudy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1037	Yes. We'll see. Someone really bailed out already today, with IDPH tradin	Howard Hoffman	-	6/24/1997
1036	Bennett and all, Yes, this is a momentary setback, but IDPH still has a lot to	Rick Costantino	-	6/24/1997
1035	Well, I guess now we'll see just how much CE9.1 was factored into price.<	Richard Belanger	-	6/24/1997
1034	Hi Bennett, Well, you were right on target with the RA therapy. Thanks for the	Roudy	-	6/24/1997
1033	Well it was nice knowing you all. IDEC's potential glory days have come to	Roader	-	6/24/1997
1032	I'm sorry to have to report this but IDEC's RA program just took it in	Webhead	-	6/24/1997
1031	I agree... BENNETT	I. Luttichuys	-	6/21/1997
1030	Hi Brad, I would expect ML to be more conservative on the rating they place on	Roudy	-	6/21/1997
1029	To all: I know that Merrill's "accumulate" is comperable to othe	Matthew Wecksell	-	6/19/1997
1028	I thank you for the very useful information. I have been thinking about this a	I. Luttichuys	-	6/19/1997
1027	Hi Bennett, I am very pleased to see that Merrill finally initiated coverage bu	Brad C. Dunlap	-	6/19/1997
1026	Hi Bennett, not necessary the news ! IDEC-C2B8 SCHEDULED FOR JULY 25 FDA ADVIS	Don Cheng	-	6/19/1997
1025	Merrill's BUY rating would equal STRONG BUY. Their ACCUMULATE rating would	Henry Niman	-	6/19/1997
1024	Howard, from Briefing.com: <b>Merrill Lynch</b> <i>Buy Accum	SilasSan	-	6/19/1997
1023	Brad, what is your take on Merrill's action? As I have just posted, I don&#	I. Luttichuys	-	6/19/1997
1022	Maybe nothing to it but, my initial reaction is that, with Eric Hecht over at M	I. Luttichuys	-	6/19/1997
1021	Howard, the short answer is that NHL (non-Hodgkin's lymphoma) is classified	Pseudo Biologist	-	6/18/1997
1020	I found the following correction (several weeks old) on AOL news: In [news r	Howard Hoffman	-	6/18/1997
1019	What are Merrill Lynch's different classifications? Is there a stronger ra	Howard Hoffman	-	6/18/1997
1018	Bennett: Is this Merrill Lynch coverage the one you have been expecting for th	AARON DIDICH	-	6/18/1997
1017	I guess I don't have to hold on very tight. That will teach me to think.	DZOO	-	6/18/1997
1016	Well, this must be Mr. Eric Hecht. Hope more good news to come !	Don Cheng	-	6/18/1997
1015	Hold on to your hats...IDEC Pharmaceuticals Corp (IDPH) 25 7/8: Merrill Lynch i	DZOO	-	6/18/1997
1014	Thanks Brad! My biotech partner was not available and this initially sounded li	DZOO	-	6/18/1997
1013	Thanks Brad, probably a typo or something which occured somewhere along the li	I. Luttichuys	-	6/17/1997

Go to reply# or date (mm/dd/yy):